000 01387 a2200385 4500
005 20250513194103.0
264 0 _c19991123
008 199911s 0 0 eng d
022 _a1524-6094
024 7 _a10.1089/jwh.1.1999.8.901
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrophy, D F
245 0 0 _aPharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidence.
_h[electronic resource]
260 _bJournal of women's health & gender-based medicine
_cSep 1999
300 _a901-17 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aCoronary Disease
_xepidemiology
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aHormone Replacement Therapy
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aHyperlipidemias
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aPostmenopause
650 0 4 _aSelective Estrogen Receptor Modulators
_xtherapeutic use
650 0 4 _aUnited States
_xepidemiology
700 1 _aCrouch, M A
700 1 _aRuffin, D M
700 1 _aWazny, L D
700 1 _aMcKenney, J M
773 0 _tJournal of women's health & gender-based medicine
_gvol. 8
_gno. 7
_gp. 901-17
856 4 0 _uhttps://doi.org/10.1089/jwh.1.1999.8.901
_zAvailable from publisher's website
999 _c10491204
_d10491204